Treatment-resistant depression (TRD) represents a major clinical and public health challenge contributing disproportionately to disability, healthcare utilisation, and societal costs. Progress in the field may be hindered by substantial heterogeneity in TRD phenotypic definitions and inconsistencies in their operationalisation across research and clinical settings. In this narrative review, we provide an updated overview of TRD research, focusing on limitations of current phenotypic frameworks,